These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26011487)

  • 61. Personalized Radiation Oncology for Breast Cancer: The New Frontier.
    Bellon JR
    J Clin Oncol; 2015 Jun; 33(18):1998-2000. PubMed ID: 25964251
    [No Abstract]   [Full Text] [Related]  

  • 62. Reply to A. Fiorentino et al.
    Bellon JR
    J Clin Oncol; 2015 Dec; 33(36):4314. PubMed ID: 26527783
    [No Abstract]   [Full Text] [Related]  

  • 63. Tracking dormant disseminated tumour cells.
    Correia AL
    Nat Rev Cancer; 2022 Jul; 22(7):379. PubMed ID: 35469002
    [No Abstract]   [Full Text] [Related]  

  • 64. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
    Simões BM; O'Brien CS; Eyre R; Silva A; Yu L; Sarmiento-Castro A; Alférez DG; Spence K; Santiago-Gómez A; Chemi F; Acar A; Gandhi A; Howell A; Brennan K; Rydén L; Catalano S; Andó S; Gee J; Ucar A; Sims AH; Marangoni E; Farnie G; Landberg G; Howell SJ; Clarke RB
    Cell Rep; 2015 Sep; 12(12):1968-77. PubMed ID: 26387946
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ligand-Independent Mechanisms of Notch Activity.
    Palmer WH; Deng WM
    Trends Cell Biol; 2015 Nov; 25(11):697-707. PubMed ID: 26437585
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
    Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
    Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Notch signaling and breast cancer.
    Reedijk M
    Adv Exp Med Biol; 2012; 727():241-57. PubMed ID: 22399352
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer.
    Rizzo P; Osipo C; Pannuti A; Golde T; Osborne B; Miele L
    Adv Enzyme Regul; 2009; 49(1):134-41. PubMed ID: 19344631
    [No Abstract]   [Full Text] [Related]  

  • 69. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.
    Hirose H; Ishii H; Mimori K; Ohta D; Ohkuma M; Tsujii H; Saito T; Sekimoto M; Doki Y; Mori M
    Oncol Rep; 2010 Jan; 23(1):35-43. PubMed ID: 19956862
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
    Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
    Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
    Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
    Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.
    Abravanel DL; Belka GK; Pan TC; Pant DK; Collins MA; Sterner CJ; Chodosh LA
    J Clin Invest; 2015 Jun; 125(6):2484-96. PubMed ID: 25961456
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeted therapies: Notching up dormant tumour-cell deaths to avoid recurrence.
    Hutchinson L
    Nat Rev Clin Oncol; 2015 Aug; 12(8):437. PubMed ID: 26011487
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.